FOR THE BEST
BRAIN & TUMOR
THERAPEUTICS
AI AND BIG-DATA DRIVEN PRECISION
NEUROLOGY AND NEURO-ONCOLOGY
view more
FOR THE BEST
BRAIN & TUMOR
THERAPEUTICS
FOR THE CURE OF REFRACTORY
BRAIN DISEASE AND CANCER
view more
FOR THE BEST
BRAIN & TUMOR
THERAPEUTICS
BRAIN-SPECIFIC THERAPEUTICS WITH
BRAIN DELIVERY PLATFORMS
view more
FOR THE BEST
BRAIN & TUMOR
THERAPEUTICS
IT’S ABOUT ALL OF US
view more

HISTORY

2018.08
AIMEDBIO Inc. was founded
2019.01
In-licensed the patents and resources from Samsung Medical Center
2019.06
Collaboration deal with a global big pharmaceutical company
2019.08
Founded a subsidiary company, AVATAMED PTE Ltd. in Singapore CBMED
2019.09
Received the certification of venture business
2019.12
AIMEDBIO R&D Center OPEN
2020.04
Genotwin, a joint venture was founded in United States.
As a next-generation genomics platform that combines leading genomics expertise with data science, Genotwin aims to transform the detection of pathogens and our understanding of individual immune responses to them.
2020.06
AIMEDBIO Inc. joins the consortium funded by Austrian government. AIMEDBIO
and CBMED will collaborate on precision medicine drug screening project CBMED
2020.07
Discovery of AMB003, a novel antibody potentially active in brain cancer therapy was filed for a patent CBMED
2020.09
Licensed-in a payload from Samsung Medical Center & Sejong University